{
    "organizations": [],
    "uuid": "d639b158de9433e2303d172943a48c1c10ca6410",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-episurf-medical-presents-strategy/brief-episurf-medical-presents-strategy-update-idUSASM000JNN",
    "ord_in_thread": 0,
    "title": "BRIEF-Episurf Medical Presents Strategy Update",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 23 (Reuters) - EPISURF MEDICAL AB:\n* EPISURF MEDICAL PRESENTS STRATEGY UPDATE, NEW EXTERNAL FINANCING AND LONG-TERM OPERATING TARGETS\n* ‍IS CLOSE TO LAUNCHING AN IMPORTANT AND COMPREHENSIVE CLINICAL MULTICENTER STUDY IN US AND EUROPE​\n* ‍HAS ENTERED INTO EARLY COLLABORATIVE DISCUSSIONS REGARDING US MARKET.​\n* ‍LONG-TERM PROFITABILITY GOAL: EPISURF MEDICAL TARGETS A LONG-TERM OPERATING MARGIN OF 40%​\n* HAS TAKEN DECISION TO PURSUE A CLINICAL STUDY AIMED AT GAINING FDA-APPROVAL FOR EPISEALER KNEE TECHNOLOGY​\n* ‍WILL ESTABLISH ITS PATIENT-SPECIFIC TECHNOLOGY IN TREATMENT ALGORITHM FOR FOCAL CARTILAGE AND BONE LESIONS​\n* ‍ESTIMATES ADDRESSABLE MARKET FOR EPISEALER KNEE IMPLANTS IN EUROPE, ASIA AND US AMOUNTS TO 150,000 PATIENTS ANNUALLY​\n* ‍SIGNED AN AGREEMENT RELATING TO A FINANCING OF UP TO SEK 70 MILLION​\n* ‍IS CONSIDERING ADDITIONAL EUROPEAN MARKETS​ * ‍ENGAGED IN DISTRIBUTOR DISCUSSIONS IN A NUMBER OF MIDDLE EASTERN MARKETS.​\n* ‍IS IN EARLY DISTRIBUTOR DISCUSSIONS FOR A NUMBER OF ASIAN MARKETS​\n* ‍AIMS AT STARTING CLINICAL STUDY FOR PURPOSE OF RECEIVING FDA APPROVAL FOR MARKETING OF EPISEALER TECHNOLOGY​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-23T15:54:00.000+02:00",
    "crawled": "2018-02-24T13:29:48.063+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "episurf",
        "medical",
        "ab",
        "episurf",
        "medical",
        "present",
        "strategy",
        "update",
        "new",
        "external",
        "financing",
        "operating",
        "target",
        "close",
        "launching",
        "important",
        "comprehensive",
        "clinical",
        "multicenter",
        "study",
        "u",
        "entered",
        "early",
        "collaborative",
        "discussion",
        "regarding",
        "u",
        "profitability",
        "goal",
        "episurf",
        "medical",
        "target",
        "operating",
        "margin",
        "taken",
        "decision",
        "pursue",
        "clinical",
        "study",
        "aimed",
        "gaining",
        "episealer",
        "knee",
        "establish",
        "technology",
        "treatment",
        "algorithm",
        "focal",
        "cartilage",
        "bone",
        "addressable",
        "market",
        "episealer",
        "knee",
        "implant",
        "europe",
        "asia",
        "u",
        "amount",
        "patient",
        "agreement",
        "relating",
        "financing",
        "sek",
        "considering",
        "additional",
        "european",
        "distributor",
        "discussion",
        "number",
        "middle",
        "eastern",
        "early",
        "distributor",
        "discussion",
        "number",
        "asian",
        "starting",
        "clinical",
        "study",
        "purpose",
        "receiving",
        "fda",
        "approval",
        "marketing",
        "episealer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}